July 17, 2018 4:06 PM ET

Healthcare Equipment and Supplies

Company Overview of Neuromod Devices Ltd.

Company Overview

Neuromod Devices Ltd., a medical device company, specializes in the research and development of neuromodulation treatments for chronic tinnitus. Its mutebutton is a bi-modal neuromodulation device that focuses on promoting positive therapeutic change in the human nervous system. The company was founded in 2010 and is based in Dublin, Ireland.


Belfield Innovation Park

Beech Hill Road

Dublin,  D04 V2N9


Founded in 2010


353 1 253 1444

Key Executives for Neuromod Devices Ltd.

Founder, Chief Executive Officer and Director
Chief Financial Officer
Chief Medical Officer
Chief Technology Officer
Chief Scientific Officer
Compensation as of Fiscal Year 2018.

Neuromod Devices Ltd. Key Developments

Neuromod Devices Limited Names Mr. Christopher M. Smith as Strategic Advisor to the Board as of June 1, 2018 and to the Board of Directors from January 3, 2019

Neuromod Devices Limited announced that Mr. Christopher M. Smith is a strategic advisor to the board as of June 1st, 2018 and will join the company’s board of directors from January 3rd, 2019. Mr. Smith comes to Neuromod’s Board with an exemplary track record of leadership in the hearing and medical devices sectors. In January 2018, after 14 years with the company, Mr. Smith retired from his role as chief executive officer and director of Cochlear Ltd. Prior to Cochlear, Mr. Smith held roles as CEO in Residence with Warburg Pincus and as group president of Gyrus Group in Reading, England. Mr. Smith has previously served on the board of directors of Xtent Inc. as well as Startek Inc, Universal Biosensors, Gyrus Group Plc, and notably Acclarent Inc.

Neuromod Devices Limited Appoints Hubert Lim as Chief Scientific Officer

Neuromod Devices Limited announced the appointment of Dr. Hubert Lim as Chief Scientific Officer. Dr. Lim is Associate Professor and Institute for Translational Neuroscience Scholar at the University of Minnesota, United States. Initially, Dr. Lim will focus on concluding Neuromod’s TENT-A tinnitus trial, currently taking place in Ireland and Germany. When complete. Dr. Lim will apply his deep insight into the evolving neuroscience of tinnitus to completing the trial and in communicating the results to the global scientific and clinical communities. Over time, Dr. Lim will play a key role as the company advances towards international markets, including regulatory applications to the US Food and Drug Administration.

Similar Private Companies By Industry

Company Name Region
Advanced Surgical Concepts Limited Europe
Aegis Surgical Limited Europe
Aerogen Limited Europe
AeroSurgical Ltd. Europe
AltaScience Limited Europe

Recent Private Companies Transactions

Private Placement
December 31, 2017

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Neuromod Devices Ltd., please visit www.neuromoddevices.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.